HAVN Life Sciences Inc. — Investor Relations & Filings
HAVN Life Sciences Inc. is a biotechnology company focused on the research, standardized extraction, and formulation of psychoactive compounds derived from plants and fungi. The company operates HAVN Labs, which is dedicated to building a quality-controlled psychedelic supply chain for clinical researchers. Its primary activities include the standardized extraction of compounds for the creation of Active Pharmaceutical Ingredients (APIs) and the development of formulations, particularly for microdosing therapies. HAVN Life supports innovative treatments addressing mental health disorders and aims to unlock human performance through evidence-informed research. The company also develops and distributes natural health care products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2023-11-10 | English | |
| News release - English.pdf | 2023-10-26 | English | |
| News release - English.pdf | 2023-10-26 | English | |
| News release - English.pdf | 2023-10-17 | English | |
| News release - English.pdf | 2023-09-19 | English | |
| Material change report - English.pdf | 2023-08-30 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 29469012 | News release - English.pdf | 2023-11-10 | English | ||
| 13700364 | News release - English.pdf | 2023-10-26 | English | ||
| 13700350 | News release - English.pdf | 2023-10-26 | English | ||
| 29313586 | News release - English.pdf | 2023-10-17 | English | ||
| 13693563 | News release - English.pdf | 2023-09-19 | English | ||
| 13689984 | Material change report - English.pdf | 2023-08-30 | English | ||
| 13689989 | News release - English.pdf | 2023-08-30 | English | ||
| 13683710 | News release - English.pdf | 2023-07-27 | English | ||
| 13683713 | Notice.pdf | 2023-07-27 | English | ||
| 13683712 | Letter from former auditor.pdf | 2023-07-27 | English | ||
| 13683711 | Letter from successor auditor.pdf | 2023-07-27 | English | ||
| 27893253 | 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-04-05 | English | ||
| 27892893 | 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-04-05 | English | ||
| 27892895 | Interim MD&A - English.pdf | 2023-04-05 | English | ||
| 27892896 | Interim financial statements/report – English.pdf | 2023-04-05 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
HAVN Life Sciences Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47913/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47913 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47913 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47913 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47913}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HAVN Life Sciences Inc. (id: 47913)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.